Case Report
Copyright ©The Author(s) 2020.
World J Clin Cases. Dec 26, 2020; 8(24): 6396-6407
Published online Dec 26, 2020. doi: 10.12998/wjcc.v8.i24.6396
Table 1 The changes of systemic lupus erythematosus in pregnancy of the patients
Time
Preconception
GA 23+ wk
GA 24+ wk
GA 24+ to 28 wk
Postpartum, 7-34 d
Related clinical manifestations and immune related indicators24-h urine protein fluctuates around 3 gALT: 197 U/L; AST: 185 U/LHb: 87 g/LCr: 176 μmol/LHb: 77 g/L
ALT: 465 U/L; AST: 525 U/LALT: 15 U/L; AST: 23 U/L
Cr: 163 μmol/LCr: 79 μmol/L
24-h urine protein 19.43 g24-h urine protein 5.81 g
C3: 0.60 g/L; C4: 0.11 g/LC3: 0.45 g/L; C4: 0.16 g/L
SLE activity index (score)4 (proteinuria)9 (proteinuria, hematuria, fever)15 (proteinuria, hematuria, cylindruria, fever)9 (proteinuria, cylindruria, fever)
ImmunosuppressantAZA (dose: 50 mg/d)AZA (dose: 75 mg/d)MP injection (dose: 500 mg/d × 3 d, 300 mg/Q12 h × 2 d)MP injection (dose: 40 mg/d, 80 mg/d × 3 d)Rituximab 100 mg × 1/2 wk
MP (dose: 4 mg /d)MP injection (dose: 500 mg/d × 3 d)Plasma adsorption therapyAZA (dose: 75 mg/d)CYC 200 mg × 2 wk
IVIg (dose: 20 g /d × 5 d)HCQ (dose: 200 mg/d)MP injection (dose: 40 + 30 mg/d × 2 d, 40 + 20 mg/d × 8 d)
TAC (0.5 mg × 1 d, 0.25 mg × 2 d)
Clinical responseHb: 93 g/LHb: 81 g/LHb: 85 g/L
ALT: 56 U/L; AST: 39 U/LALT: 282 U/L; AST: 130 U/LALT: 23 U/L; AST: 10 U/L
Cr: 102 μmol/LCr: 136 μmol/LCr: 82 μmol/L
24-h urine protein fluctuates around 19.68 g24-h urine protein 4.40 g
C3: 0.52 g/L; C4: 0.10 g/LC3: 0.68 g/L; C4: 0.18 g/L
Table 2 Related clinical manifestations and immune indicators of the patient
Serial
No.
Diagnostic indexes
Clinical manifestation 1Fever (37.6-40 °C)
2Acute cutaneous lupus erythematosus (“butterfly rash”, “discoid Rash”)
3Serositis (lung CT images: Serous membrane fluid)
4Synovitis (mild joint pain of wrist joint of both hands)
5Blood system involvement (leukopenia 2.3 × 109/L, hemolytic anemia 95 g/L, thrombocytopenia 50 × 109/L; ESR 37 mmHg)
6Renal system involvement (24-h urine protein 5422.00 mg; RBC under microscope: ++/HP, protein: +2, RBC morphological information: Heterogeneous cell type)
7Aphthous ulcers
Immunological indicators8ANA level above laboratory reference range (1:1000)
9Anti-dsDNA antibodies (+)
10Anti-SSA (+)
11Anti-Sm antibodies (+)
12Antiphospholipid antibodies (IgA 4.21 mg/L, IgG 18.5 g/L)
13Low complement (C3: 0.21 g/L, C4: 0.04 g/L)
14CD3+CD4+CD28CD4 (37.0%)